← Every company
Pacira Biosciences Inc SEC Filings
What Pacira Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
PCRX overview →Filings on file
164
since Nov 2, 2016
Warning signs
1
latest Jun 29, 2017
Last results
Aug 4, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 11, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jan 28, 2026 | Executive or director change 8-K | Read ↗ |
| Jun 13, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jan 30, 2025 | Executive or director change 8-K | Read ↗ |
| Jan 21, 2025 | Executive or director change 8-K | Read ↗ |
| Nov 6, 2024 | Executive or director changeResults announced 8-K | Read ↗ |
| Oct 21, 2024 | Executive or director change 8-K | Read ↗ |
| Sep 27, 2024 | Executive or director change 8-K | Read ↗ |
| Jun 13, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 29, 2024 | Executive or director changeResults announced 8-K | Read ↗ |
| Dec 21, 2023 | Executive or director change 8-K | Read ↗ |
| Oct 10, 2023 | Executive or director change 8-K | Read ↗ |
| Sep 26, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 20, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 22, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 10, 2022 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 4, 2022 | Executive or director changeResults announced 8-K | Read ↗ |
| Jun 17, 2021 | Executive or director change 8-K | Read ↗ |
| Jun 11, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Dec 7, 2020 | Executive or director change 8-K | Read ↗ |
| Jun 11, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jan 10, 2020 | Executive or director change 8-K | Read ↗ |
| Sep 19, 2019 | Executive or director change 8-K | Read ↗ |
| Jun 19, 2019 | Executive or director change 8-K | Read ↗ |
| Jun 7, 2019 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 29, 2018 | Executive or director change 8-K | Read ↗ |
| Dec 7, 2017 | Executive or director change 8-K | Read ↗ |
| Jun 15, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 23, 2017 | Executive or director change 8-K | Read ↗ |
Source: Pacira Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on PCRX
Company overviewEverything on PCRX in one place, with the price.Insider tradingWhat PCRX's own officers and directors buy and sell.Planned salesSales PCRX insiders have filed notice of.Who owns itEvery manager reporting a position in PCRX.Funds holding itWhich funds and ETFs hold PCRX, and how big a bet.